- Home
- CTSH vs GH Comparison
CTSH vs GH Comparison
Compare CTSH & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CTSH | GH |
|---|---|---|
| Founded | 1994 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.3B | 20.6B |
| IPO Year | 1998 | 2018 |
Fundamental Metrics
Financial Performance| Metric | CTSH | GH |
|---|---|---|
| Price | $58.90 | $157.09 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 19 |
| Target Price | $80.47 | ★ $119.79 |
| AVG Volume (30 Days) | ★ 8.9M | 1.9M |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.41% | N/A |
| EPS Growth | 1.11 | ★ 6.74 |
| EPS | ★ 1.39 | N/A |
| Revenue | ★ $21,108,000,000.00 | $982,021,000.00 |
| Revenue This Year | $8.17 | $33.30 |
| Revenue Next Year | $5.06 | $28.27 |
| P/E Ratio | $42.66 | ★ N/A |
| Revenue Growth | 6.95 | ★ 32.88 |
| 52 Week Low | $37.08 | $53.40 |
| 52 Week High | $87.03 | $176.58 |
Technical Indicators
Market Signals| Indicator | CTSH | GH |
|---|---|---|
| Relative Strength Index (RSI) | 73.57 | 51.09 |
| Support Level | $58.75 | $152.64 |
| Resistance Level | $62.66 | $175.33 |
| Average True Range (ATR) | 2.74 | 7.48 |
| MACD | 0.52 | -0.35 |
| Stochastic Oscillator | 92.25 | 45.32 |
Price Performance
Historical ComparisonAbout CTSH Cognizant Technology Solutions Corporation
Cognizant Technology Solutions is a multinational IT services provider that offers a range of consulting and business process outsourcing services. Originally founded in India, the company is headquartered in the US and serves enterprise customers spanning the financial services, healthcare, and resources industries. With most of its workforce located in India, Cognizant leverages a global delivery model that helps clients outsource their IT needs to offshore labor.
About GH Guardant Health Inc.
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.